Kansas City, Kansas 66160


The purpose of this study is to evaluate the feasibility of detecting atrial fibrillation (AF) in patients with AF using a wearable wrist device/smart watch.

Study summary:

Even though AF is common and associated with increased risk of stroke, quite often it goes undetected until late in the course of the condition. If AF can be detected with simpler tools like a smart watch, it would enable providers to identify patients with AF much earlier in the course of the condition (even before being seen by a physician) and hopefully be able to prevent stroke. This study is being done to identify a technology that can likely identify AF using a smart watch.


Inclusion Criteria: - All patients with AF scheduled to undergo electrical cardioversion at the University of Kansas Health System Exclusion Criteria: - Patients with no detectable PPG - Hemodynamically unstable patients - Patients who cannot give informed consent - Patients with tattoos on the wrists



Primary Contact:

Principal Investigator
Yeruva Madhu Reddy, MD
University of Kansas Medical Center

Nicole Schwab
Phone: 913-945-6442
Email: nschwab@kumc.edu

Backup Contact:


Location Contact:

Kansas City, Kansas 66160
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.